Asking the right questions: developing evidencebased strategies for treating HIV in women and children

Karim, Quarraisha Abdool; Banegura, Anchilla; Cahn, Pedro; Christie, Celia D. C.; Dintruff, Robert; Distel, Manuel; Hankins, Catherine; Hellmann, Nicholas; Katabira, Elly; Lehrman, Sandra; Montaner, Julio; Purdon, Scott; Rooney, James F.; Wood, Robin; Heidari, Shirin
January 2011
BMC Public Health;2011 Supplement 4, Vol. 11 Issue Suppl 4, p388
Academic Journal
In July 2010, the World Health Organization (WHO) issued formal revisions of its guidelines on the use of highly active antiretroviral therapy for HIV. The new guidelines greatly expand eligibility for treatment of adults and children, as well as for pregnant women seeking prophylaxis for vertical HIV transmission. WHO's new recommendations bring the guidelines closer to practices in developed countries, and its shift to earlier treatment alone will increase the number of treatment-eligible people by 50% or more. Scaling up access to HIV treatment is revealing important gaps in our understanding of how best to provide for all those in need. This knowledge gap is especially significant in developing countries, where women and children comprise a majority of those living with HIV infection. Given the magnitude and significance of these populations, the International AIDS Society, through its Industry Liaison Forum, prioritized HIV treatment and prophylaxis of women and children. In March 2010, the International AIDS Society and 15 partners launched a Consensus Statement outlining priority areas in which a relative lack of knowledge impedes delivery of optimal prevention of mother to child transmission (PMTCT) and treatment to women and children. The Consensus Statement, "Asking the Right Questions: Advancing an HIV Research Agenda for Women and Children", makes a special appeal for a more gender-sensitive approach to HIV research at all stages, from conception to design and implementation. It particularly emphasizes research to enhance the understanding of sex-based differences and paediatric needs in treatment uptake and response. In addition to clinical issues, the statement focuses on programmatic research that facilitates access and adherence to antiretroviral regimens. Better coordination of HIV management with sexual and reproductive healthcare delivery is one such approach. We discuss here our knowledge gaps concerning effective, safe PMTCT and treatment for women and children in light of the expansion envisioned by WHO's revised guidelines. The guideline's new goals present an opportunity for advancing the women and children's agenda outlined in the Consensus Statement.


Related Articles

  • THE HIV PREVENTION RESOURCE GAP.  // Foreign Affairs;May/Jun2003 Supplement, Vol. 82 Issue 3, p32 

    In every region, substantial gaps exist in access to essential HIV prevention interventions. A major effort to mobilize resources for HIV prevention programs, coupled with the scale-up of treatment programs, will be needed to reverse the global epidemic. Optimal worldwide access to harm...

  • Next trial for Starpharma.  // Australian Life Scientist;8/13/2008, p1 

    Starpharma studies VivaGel duration

  • HIV-associated nephropathy: a diagnosis in evolution. Ray, Patricio E. // Nephrology Dialysis Transplantation;Nov2012, Vol. 27 Issue 11, p3969 

    HIV-1 associated nephropathy (HIVAN) is a clinical and renal histological disease characterized by the presence of heavy proteinuria associated with focal segmental glomerulosclerosis and microcystic tubular dilatation. These renal lesions lead to renal enlargement and rapid progression to...

  • Causes of the decline in AIDS deaths, United States, 1995–2002: prevention, treatment or both? Holtgrave, David R. // International Journal of STD & AIDS;Dec2005, Vol. 16 Issue 12, p777 

    The decline in AIDS deaths in the USA between 1995 and 2002 has been attributed by Centers for Disease Control (CDC) to HIV treatments advances. The purpose of the present study is to assess whether this AIDS deaths decline was due entirely to treatment advances, to earlier prevention successes,...

  • Heterologous protection elicited by candidate monomeric recombinant HIV-1 gp120 vaccine in the absence of cross neutralising antibodies in a macaque model. Page, Mark; Stebbings, Richard; Berry, Neil; Hull, Robin; Ferguson, Deborah; Davis, Leanne; Duffy, Laura; Elsley, William; Hall, Joanna; Ham, Claire; Hassall, Mark; Bo Li; Mee, Edward T.; Quartey-Papafio, Ruby; Rose, Nicola J.; Mathy, Nathalie; Voss, Gerald; Stott, E. James; Almond, Neil // Retrovirology;2012, Vol. 9 Issue 1, p56 

    Background: Current data suggest that an efficacious human immunodeficiency virus type 1 (HIV-1) vaccine should elicit both adaptive humoral and cell mediated immune responses. Such a vaccine will also need to protect against infection from a range of heterologous viral variants. Here we have...

  • Measuring Coverage in MNCH: Population HIV-Free Survival among Children under Two Years of Age in Four African Countries Stringer, Jeffrey S. A.; Stinson, Kathryn; Tih, Pius M.; Giganti, Mark J.; Ekouevi, Didier K.; Creek, Tracy L.; Welty, Thomas K.; Chi, Benjamin H.; Wilfert, Catherine M.; Shaffer, Nathan; Stringer, Elizabeth M.; Dabis, Francois; Coetzee, David // PLoS Medicine;May2013, Vol. 10 Issue 5, p1 

    Background: Population-based evaluations of programs for prevention of mother-to-child HIV transmission (PMTCT) are scarce. We measured PMTCT service coverage, regimen use, and HIV-free survival among children ≤24 mo of age in Cameroon, Côte D'Ivoire, South Africa, and Zambia. ...

  • Preventive Antiretroviral Use Expands: Approved for HIV Exposure Outside of Work Settings. Voelker, Rebecca // JAMA: Journal of the American Medical Association;3/9/2005, Vol. 293 Issue 10, p1177 

    Reports on the expansion of the use of antiretroviral drugs to prevent HIV infection following nonoccupational exposure to the virus. How sufficient evidence exists for the United States to sanction antiretrovirals to be used in such a manner; Caution of experts about their use; Guidelines for...

  • Towards an understanding of barriers to condom use in rural Benin using the Health Belief Model: A cross sectional survey. Hounton, Sennen H.; Carabin, Hélène; Henderson, Neil J. // BMC Public Health;2005, Vol. 5, p8 

    Background: HIV/AIDS is the most dramatic epidemic of the century that has claimed over two decade more than 3 million deaths. Sub Saharan Africa is heavily affected and accounts for nearly 70% of all cases. Despite awareness campaigns, prevention measures and more recently promotion of anti...

  • Early Experiences Implementing Pre-exposure Prophylaxis (PrEP) for HIV Prevention in San Francisco. Liu, Albert; Cohen, Stephanie; Follansbee, Stephen; Cohan, Deborah; Weber, Shannon; Sachdev, Darpun; Buchbinder, Susan // PLoS Medicine;Mar2014, Vol. 11 Issue 3, p1 

    : Albert Liu and colleagues report early experiences with uptake and delivery of pre-exposure prophylaxis(PrEP)for HIV prevention in three different settings in San Francisco. PrEP can be an important component of a comprehensive HIV prevention program and can complement efforts to increase HIV...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics